<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This is a major cause of morbidity and mortality </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a 17-year-old male patient diagnosed with severe idiopathic acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> who developed fungal <z:e sem="disease" ids="C0032285" disease_type="Disease or Syndrome" abbrv="PNEUM">pneumonitis</z:e> due to Rhizomucor sp. and rhinoencephalitis due to Scedosporium apiospermum 6 and 8 months after undergoing allogeneic hematopoietic stem-cell transplant from an HLA-matched unrelated donor </plain></SENT>
<SENT sid="3" pm="."><plain>Discussion highlights risk factors for invasive <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infections</z:e> (i.e., <z:e sem="disease" ids="C0026718" disease_type="Disease or Syndrome" abbrv="">mucormycosis</z:e> and scedosporiosis), its clinical features, and the factors that must be taken into account to successfully treat them (early diagnosis, correction of predisposing factors, aggressive surgical debridement, and antifungal and adjunctive therapies) </plain></SENT>
</text></document>